Biotech
LAVAL, QUEBEC: Clinical program to commence in Q4 2014 PBI-4050 to target insulin resistance and loss of pancreatic insulin production, the fundamental mechanisms in type 2 diabetes ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwired) -- 12/03/14 -- Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk ass ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 12/03/14 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today, through its U.S. opera ...
TUSTIN, CA: TUSTIN, CA -- (Marketwired) -- 12/03/14 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (NASDAQ: PPHMP), a biopharmaceutical company developing first-in-class monoclonal antibodies for the treatmen ...
NORWOOD, MA: Live Webcast on Wednesday, December 10, at 8:35 a.m. EST ...
ANN ARBOR, MI: Company Strengthens Leadership by Naming Chief Science Officer, Chief Medical Officer and SVP of Operations ...
EVANSTON, IL: First Study of Its Kind by ZS Sizes the Fast-Growing POC Marketing Channel ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/02/14 -- InMed Pharmaceuticals Inc. ("InMed") (CSE: IN)(OTCQB: IMLFF), a clinical stage biopharmaceutical company that specializes in dev ...
SAN ANTONIO, TEXAS: SAN ANTONIO, TEXAS -- (Marketwired) -- 12/01/14 -- Nerium Biotechnology, Inc. (the "Company"), announced today that, due to a mathematical formula error in its equity investment calculatio ...
EXTON, PA: EXTON, PA -- (Marketwired) -- 12/01/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the automatic conversion of the 4% convertible junior subordinated debentures due March 15, 20 ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 12/01/14 -- Flamel Technologies (NASDAQ: FLML) announced today that it has closed the sale of its development and manufacturing facility located in Pessac, France, to ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 12/01/14 -- (OTCBB: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing i ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 11/28/14 -- Flamel Technologies (NASDAQ: FLML) announced today that it has entered into an agreement to divest its development and manufacturing facility located in P ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwired) -- 11/27/14 -- Miraculins Inc. (TSX VENTURE: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing dia ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/26/14 -- As a result of the settlement of debt of the Jenex Corporation (the "Corporation) (TSX VENTURE: JEN.H) and accrued interest thereon, Mr. David W ...
EDMONTON, ALBERTA: Ceapro's PGX Technology enables production of pharmaceutical grade Beta Glucan ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/26/14 -- Arch Biopartners Inc (CSE: ACH)(OTCBB: FOIFF) has now completed a Clinical Development Plan ("CDP") to prepare a human trial for MetaMx, th ...
LONDON, ONTARIO: Funding better positions the Company and COTI-2 for Phase 1 Clinical study ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/26/14 -- RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (TSX VENTURE: RP) (OTCQB: REPCF), a clinical stage regenerat ...
